Background: Previous studies suggested that alterations in serum cortisol and DHEA-S levels may play a role in the pathophysiology of schizophrenia.
Aim: To compare serum cortisol and DHEA-S levels between patients with schizophrenia and healthy controls and to evaluate their association with the response to antipsychotic treatment.
Material And Methods: In this clinical prospective study were included 60 patients with schizophrenia and 40 healthy age and sex matched control subjects.